Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension, Journal of the American College of Cardiology, vol.52, issue.25, pp.217-251, 2008. ,
DOI : 10.1016/j.jacc.2008.08.059
Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses, Proceedings of the American Thoracic Society, vol.3, issue.7, pp.601-608, 2006. ,
DOI : 10.1513/pats.200605-111LR
Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases, Respiration, vol.76, issue.3, pp.295-302, 2008. ,
DOI : 10.1159/000112822
URL : https://hal.archives-ouvertes.fr/hal-00356272
Pulmonary hypertension in type I glycogen storage disease, Pediatric Cardiology, vol.37, issue.1, pp.54-60, 1990. ,
DOI : 10.1007/BF02239550
Echocardiographic assessment of pulmonary hypertension in Gaucher's disease, The Lancet, vol.351, issue.9115, pp.1544-1550, 1998. ,
DOI : 10.1016/S0140-6736(98)10194-0
High Prevalence of Autoimmune Thyroid Disease in Pulmonary Arterial Hypertension, Chest, vol.122, issue.5, pp.1668-73, 2002. ,
DOI : 10.1378/chest.122.5.1668
Primary pulmonary artery sarcoma: A report of six cases, The Annals of Thoracic Surgery, vol.59, issue.6, pp.1487-90, 1995. ,
DOI : 10.1016/0003-4975(95)00149-F
Mediastinal fibrosis1, Seminars in Respiratory Infections, vol.16, issue.2, pp.119-149, 2001. ,
DOI : 10.1053/srin.2001.24242
Pulmonary Hypertension in Patients With End-Stage Renal Disease, Chest, vol.123, issue.5, pp.1577-82, 2003. ,
DOI : 10.1378/chest.123.5.1577
Primary pulmonary hypertension, The Lancet, vol.352, issue.9129, pp.719-725, 1998. ,
DOI : 10.1016/S0140-6736(98)02111-4
Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.107, issue.2, pp.216-223, 1987. ,
DOI : 10.7326/0003-4819-107-2-216
Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation, pp.2797-2802 ,
Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance, European Heart Journal, vol.27, issue.23, pp.2879-88, 2007. ,
DOI : 10.1093/eurheartj/ehl336
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers, Journal of the American College of Cardiology, vol.48, issue.12, pp.2546-52, 2006. ,
DOI : 10.1016/j.jacc.2006.07.061
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension, Circulation, vol.111, issue.23, pp.3105-3111, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.104.488486
Primary Pulmonary Hypertension, Chest, vol.105, issue.2, pp.33-36, 1994. ,
DOI : 10.1378/chest.105.2_Supplement.33S
Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-352, 1991. ,
DOI : 10.7326/0003-4819-115-5-343
Evaluation de la fonction cardiaque droite. Revues générales échocardiographique 51 ,
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.39, issue.7, pp.1214-1223, 2002. ,
DOI : 10.1016/S0735-1097(02)01744-8
Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-349, 1991. ,
DOI : 10.7326/0003-4819-115-5-343
Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension, European Respiratory Journal, vol.17, issue.4, pp.647-52, 2001. ,
DOI : 10.1183/09031936.01.17406470
Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.161, issue.2, pp.487-492, 2000. ,
DOI : 10.1164/ajrccm.161.2.9906015
Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.160, issue.2, pp.487-92, 1999. ,
DOI : 10.1164/ajrccm.160.2.9812078
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension, Circulation, vol.102, issue.8, pp.865-70, 2000. ,
DOI : 10.1161/01.CIR.102.8.865
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension, Circulation, vol.108, issue.7, pp.844-852, 2003. ,
DOI : 10.1161/01.CIR.0000084544.54513.E2
Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.12, pp.1364-1373, 2008. ,
DOI : 10.1164/rccm.200712-1876OC
Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension, Chest, vol.120, issue.5, pp.1562-1571, 2001. ,
DOI : 10.1378/chest.120.5.1562
MEDICAL THERAPY OF PULMONARY HYPERTENSION, Clinics in Chest Medicine, vol.22, issue.3, pp.517-544, 2001. ,
DOI : 10.1016/S0272-5231(05)70288-4
Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?, European Heart Journal, vol.30, issue.3, pp.256-65, 2009. ,
DOI : 10.1093/eurheartj/ehn597
Hypertension art??rielle pulmonaire f??minine, Revue des Maladies Respiratoires, vol.25, issue.4, pp.451-60, 2008. ,
DOI : 10.1016/S0761-8425(08)71585-7
Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1???mg/Ethinylestradiol 35?????g in Healthy Subjects, Clinical Drug Investigation, vol.75, issue.5, pp.313-337, 2010. ,
DOI : 10.2165/11534940-000000000-00000
Pregnancy and contraception in heart disease and pulmonary arterial hypertension, Journal of Family Planning and Reproductive Health Care, vol.32, issue.2, pp.75-80, 2006. ,
DOI : 10.1783/147118906776276486
Non-cardiothoracic non obstetric surgery in mild-moderate pulmonary hypertension : Perioperative management of 28 consecutive individual cases, Eur Respir J, vol.35, pp.1-9, 2010. ,
Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease, Am Rev Respir Dis, pp.131493-498, 1985. ,
Primary pulmonary hypertension: natural history and the importance of thrombosis, Circulation, vol.70, issue.4, pp.70580-70587, 1984. ,
DOI : 10.1161/01.CIR.70.4.580
The Short-term Effects of Digoxin in Patients With Right Ventricular Dysfunction From Pulmonary Hypertension, Chest, vol.114, issue.3, pp.787-792, 1998. ,
DOI : 10.1378/chest.114.3.787
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension, New England Journal of Medicine, vol.327, issue.2, pp.76-81, 1992. ,
DOI : 10.1056/NEJM199207093270203
Traitement de l???hypertension art??rielle pulmonaire, La Presse M??dicale, vol.39, pp.1-22, 2010. ,
DOI : 10.1016/S0755-4982(10)70004-X
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study, The Lancet, vol.358, issue.9288, pp.1119-1142, 2001. ,
DOI : 10.1016/S0140-6736(01)06250-X
Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study, Circulation, vol.114, issue.1, pp.48-54, 2006. ,
DOI : 10.1161/CIRCULATIONAHA.106.630715
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial, The Lancet, vol.371, issue.9630, pp.2093-100, 2008. ,
DOI : 10.1016/S0140-6736(08)60919-8
Survival with first-line bosentan in patients with primary pulmonary hypertension, European Respiratory Journal, vol.25, issue.2, pp.244-253, 2005. ,
DOI : 10.1183/09031936.05.00054804
Results of European post-marketing surveillance of bosentan in pulmonary hypertension, European Respiratory Journal, vol.30, issue.2, pp.338-382, 2007. ,
DOI : 10.1183/09031936.00138706
Ambrisentan Therapy for Pulmonary Arterial Hypertension, Journal of the American College of Cardiology, vol.46, issue.3, pp.529-564, 2005. ,
DOI : 10.1016/j.jacc.2005.04.050
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2, Circulation, vol.117, issue.23, pp.3010-3019, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.107.742510
Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities, Chest, vol.135, issue.1, pp.122-129, 2009. ,
DOI : 10.1378/chest.08-1028
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.353, issue.20, pp.2148-57, 2005. ,
DOI : 10.1056/NEJMoa050010
Tadalafil Therapy for Pulmonary Arterial Hypertension, Circulation, vol.119, issue.22, pp.2894-903, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.839274
Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study, European Respiratory Journal, vol.36, issue.4, pp.792-801, 2010. ,
DOI : 10.1183/09031936.00182909
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension, New England Journal of Medicine, vol.334, issue.5, pp.296-302, 1996. ,
DOI : 10.1056/NEJM199602013340504
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.40, issue.4, pp.780-788, 2002. ,
DOI : 10.1016/S0735-1097(02)02012-0
The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.34, issue.4, pp.34-1184, 1999. ,
DOI : 10.1016/S0735-1097(99)00320-4
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.165, issue.6, pp.800-804, 2002. ,
DOI : 10.1164/ajrccm.165.6.2106079
Inhaled Iloprost for Severe Pulmonary Hypertension, New England Journal of Medicine, vol.347, issue.5, pp.322-331, 2002. ,
DOI : 10.1056/NEJMoa020204
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.42, issue.1, pp.158-164, 2006. ,
DOI : 10.1016/S0735-1097(03)00555-2
Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension, Eur Respir J, vol.24, pp.1007-1010, 2004. ,
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension, European Respiratory Journal, vol.29, issue.3, pp.469-475, 2007. ,
DOI : 10.1183/09031936.00081706
Atrial Septostomy in Treatment of End-Stage Right Heart Failure in Patients With Pulmonary Hypertension, Chest, vol.131, issue.4, pp.977-83, 2007. ,
DOI : 10.1378/chest.06-1227
ATRIAL SEPTOSTOMY FOR PULMONARY HYPERTENSION, Clinics in Chest Medicine, vol.22, issue.3, pp.547-60, 2001. ,
DOI : 10.1016/S0272-5231(05)70291-4
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension, Journal of the American College of Cardiology, vol.32, issue.2, pp.297-304, 1998. ,
DOI : 10.1016/S0735-1097(98)00238-1
Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Lung and Heart???Lung Transplantation Report???2006, The Journal of Heart and Lung Transplantation, vol.25, issue.8, pp.880-92, 2006. ,
DOI : 10.1016/j.healun.2006.06.001
Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-352, 1991. ,
DOI : 10.7326/0003-4819-115-5-343
Primary Pulmonary Hypertension, Chest, vol.105, issue.2, pp.33-365, 1994. ,
DOI : 10.1378/chest.105.2_Supplement.33S
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study, Arthritis & Rheumatism, vol.351, issue.12, pp.3792-800, 2005. ,
DOI : 10.1002/art.21433
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease, New England Journal of Medicine, vol.350, issue.9, pp.886-95, 2004. ,
DOI : 10.1056/NEJMoa035477
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.1, pp.108-121, 2008. ,
DOI : 10.1164/rccm.200704-541OC
Survival in patients with primary pulmonary hypertension. Results from a national prospective study, Ann Intern Med, pp.343-352, 1991. ,
Hypertension art??rielle pulmonaire associ??e aux connectivites, Revue des Maladies Respiratoires, vol.23, issue.4, pp.61-72, 2006. ,
DOI : 10.1016/S0761-8425(06)71798-3
Pulmonary artery hypertension associated with connective tissue diseases, Press Med, vol.32, pp.789-99, 2003. ,
Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006. ,
DOI : 10.1164/rccm.200510-1668OC
Prognostic Factors for Survival in Human Immunodeficiency Virus???associated Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.10, pp.1433-1442, 2003. ,
DOI : 10.1164/rccm.200204-330OC
Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006. ,
DOI : 10.1164/rccm.200510-1668OC
Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006. ,
DOI : 10.1164/rccm.200510-1668OC
Survival in patients with primary pulmonary hypertension. Results from a national prospective study, Ann Intern Med, pp.343-352, 1991. ,
Micrococcus-Associated Central Venous Catheter Infection in Patients With Pulmonary Arterial Hypertension, Chest, vol.126, issue.1, pp.90-94, 2004. ,
DOI : 10.1378/chest.126.1.90
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension, European Heart Journal, vol.26, issue.18, pp.1895-902, 2005. ,
DOI : 10.1093/eurheartj/ehi283
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease, Annals of Internal Medicine, vol.132, issue.6, pp.425-459, 2000. ,
DOI : 10.7326/0003-4819-132-6-200003210-00002